Cambridge, Mass., April 27 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. announced today that its annual meeting of stockholders will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )
Millennium senior management will provide an overview of the Company and progress against 2006 goals. The presentation will be delivered at 10:00 a.m. ET on Thursday, May 4, 2006 from The Charles Hotel in Cambridge, Mass. The presentation will be archived for 30 days.
About Millennium
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.
Contact: Kyle Kuvalanka, Investor Relations (617) 761-4734
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comMillennium Pharmaceuticals, Inc.CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Investor Relations,+1-617-761-4734
Web site: http://www.millennium.com//
Company News On-Call: http://www.prnewswire.com/comp/114562.html /
